Insiders · Profile

SANG CHARLES

SVP, External Affairs at Adaptive Biotechnologies. Filing since 15 May 2020. CIK 0001780656

Company
Date
Role
Action
Shares
Amount
Of holding
11 Dec 2020
SVP, External Affairs
Sold, plan not stated
50,000
$2.81M
100%
15 Sep 2020
SVP, External Affairs
Sold, plan not stated
25,000
$1.10M
100%
14 Sep 2020
SVP, External Affairs
Sold, plan not stated
25,000
$1.06M
100%
15 May 2020
SVP, Clinical Diagnostics
Sold, plan not stated
40,000
$1.52M
100%
4 decisions on file.